Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-21-000197
Filing Date
2021-09-28
Accepted
2021-09-28 17:48:31
Documents
1
Period of Report
2021-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163286569005826.html 4  
1 FORM 4 wf-form4_163286569005826.xml 4 3339
  Complete submission text file 0001651308-21-000197.txt   5159
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Reporting) CIK: 0001651308 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 211288575
SIC: 2834 Pharmaceutical Preparations